For its fourth fiscal quarter (ending December 31), CME Group Inc (NASDAQ: CME) has reported a 7% increase in E.P.S. from $2.24 a year ago to $2.40 in the current quarter. However, this performance was $-0.05 short of the consensus estimate of $2.44. E.P.S. were $9.69 for the latest four quarters through December 31 versus $8.87 for the same period a year ago — an increase of 9%.
Recent Price Action
CME Group Inc (NASDAQ: CME) stock enjoyed a large increase of 3.0% on 2/12/25. The stock closed at $248.96. Moreover, this advance was accompanied by above average trading volume at 132% of normal. The stock has been strong relative to the market over the last nine months and has risen 2.7% during the last week.
Current PriceTarget Research Rating
CME Group has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CME Group has a poor Appreciation Score of 30 but a good Power Rating of 82, producing the Neutral Value Trend Rating.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment